Bud & Mary’s is the first to receive a Cannabis Research License in the United States for clinical trials.
Bud & Mary’s is the first pharmaceutical-type cannabis company to obtain a GMP and GAP (Good Agricultural Practices) certification in the United States.
We’ve teamed up with industry experts, including: a neurologist MD, a neuro-inflammatory blood biomarker analysis company, and a brain scan company.
This study is the first randomized placebo-controlled clinical trial to use and dispense purposefully formulated cannabis-derived medicines.
Bud & Mary’s conducts this research in effort to correlate symptomatic improvements with psychological benefits.